Boothbay Fund Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $907K | Buy |
34,235
+18,200
| +114% | +$482K | 0.02% | 554 |
|
|
2025
Q1 | $387K | Buy |
+16,035
| New | +$387K | 0.01% | 804 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1717 |
|
|
2024
Q3 | – | Sell |
-61,790
| Closed | -$3.28M | – | 1737 |
|
|
2024
Q2 | $3.28M | Buy |
61,790
+50,097
| +428% | +$2.66M | 0.08% | 288 |
|
|
2024
Q1 | $959K | Buy |
+11,693
| New | +$959K | 0.02% | 655 |
|
|
2023
Q2 | – | Sell |
-15,513
| Closed | -$258K | – | 2051 |
|
|
2023
Q1 | $258K | Sell |
15,513
-36,813
| -70% | -$613K | 0.01% | 1370 |
|
|
2022
Q4 | $492K | Buy |
52,326
+2,981
| +6% | +$28K | 0.01% | 985 |
|
|
2022
Q3 | $134K | Sell |
49,345
-53,768
| -52% | -$146K | ﹤0.01% | 1687 |
|
|
2022
Q2 | $298K | Buy |
103,113
+42,706
| +71% | +$123K | 0.01% | 1266 |
|
|
2022
Q1 | $181K | Buy |
60,407
+11,127
| +23% | +$33.3K | ﹤0.01% | 1534 |
|
|
2021
Q4 | $227K | Hold |
49,280
| – | – | 0.01% | 1258 |
|
|
2021
Q3 | $309K | Sell |
49,280
-27,056
| -35% | -$170K | 0.01% | 1093 |
|
|
2021
Q2 | $457K | Sell |
76,336
-8,804
| -10% | -$52.7K | 0.01% | 917 |
|
|
2021
Q1 | $539K | Buy |
+85,140
| New | +$539K | 0.02% | 732 |
|
|
2020
Q2 | – | Sell |
-24,016
| Closed | -$112K | – | 996 |
|
|
2020
Q1 | $112K | Hold |
24,016
| – | – | 0.01% | 622 |
|
|
2019
Q4 | $193K | Buy |
+24,016
| New | +$193K | 0.02% | 610 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 812 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 804 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 817 |
|
|
2018
Q3 | – | Sell |
-23,333
| Closed | -$221K | – | 838 |
|
|
2018
Q2 | $221K | Buy |
+23,333
| New | +$221K | 0.02% | 468 |
|
|
2018
Q1 | – | Sell |
-53,158
| Closed | -$216K | – | 774 |
|
|
2017
Q4 | $216K | Buy |
+53,158
| New | +$216K | 0.03% | 489 |
|